INTUITIVE BIOTECHNOLOGIES OFFERS NOVEL, COST EFFICIENT, AND TIME SAVING ALTERNATIVES TO ANIMAL TESTING FOR THE HEALTHCARE INDUSTRY

PRESS RELEASE
DATE: 19March2019

INTUITIVE BIOTECHNOLOGIES OFFERS NOVEL, COST EFFICIENT, AND TIME SAVING ALTERNATIVES TO ANIMAL TESTING FOR THE HEALTHCARE INDUSTRY

INTUITIVE BIOTECHNOLOGIES (IBT) is an innovative startup focusing on analytical test-ing of biological samples. It is located at the Pasadena Bio Collaborative Incubator (PBC) in Pasadena, CA. Our company is developing in vitro methodologies to reduce and eventually re-place animal testing.

The reduced use of animal testing in the development and manufacturing of healthcare, cosmetic, and nutritional products has been the focus of much international effort. While many factors have prevented the transition to alternative techniques, recent innovations that allow simultaneous characterization and quantification of multiple protein targets have paved the way to develop viable in vitro alternatives to some routine animal tests.

Our prime focus is to provide accurate and reliable biomarker screening services to
organizations that require analytical characterization of their biological samples. We specialize in producing innovative, rapid and low-cost assays for quantification and/or functional charac-terization of cell surface markers and secreted proteins using flow cytometry and other plat-forms.

IBT Director of Product Development, Dr. Brigitte Angenieux, explains, “At IBT, we un-derstand that in addition to the ethical implications surrounding animal testing, the impact of its high cost and long-time frames creates a demand for alternative tests. We focus on developing assays that will enhance the work flow and optimize the resource allocation of our clients by providing them with reliable surrogates for animal testing.”

IBT is dedicated to collaborating with and providing expertise to our clients through de-livering solutions that meet their specific needs.

To learn more about Intuitive Biotechnologies, please contact Brigitte Angenieux at [email protected].

Share

twitterlinkedinmail

About the Author and BIOCOM CRO Board Member